Analyzing the Future of Veterinary Autoimmune Disease Therapeutics Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What key factors are powering the surge in the veterinary autoimmune disease therapeutics market right now?
In recent times, there has been strong growth in the market size of therapeutics for veterinary autoimmune diseases. This market is expected to expand from a size of $3.25 billion in 2024 to $3.47 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The growth observed in the historic period can be traced back to developments in immunology, a surge in pet ownership, enhancement in diagnostic techniques, innovation in drug classes, and increasing awareness regarding pet health.
How fast Is the veterinary autoimmune disease therapeutics market expected to grow, and what’s its future value?
The market size for therapeutic treatment of veterinary autoimmune diseases is poised to witness a solid expansion in the ensuing years, potentially reaching $4.48 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.6%. This projected growth can be linked to advancements in biotechnology and increased investment in veterinary healthcare. It’s also driven by a rising incidence of autoimmune diseases in pets, the introduction of innovative treatments, and an uptick in pet insurance adoption. Future market trends to watch for include personalized medical treatments, utilization of biological medications, incorporation of telemedicine, the use of regenerative therapies, venturing towards more holistic and integrative treatment methods.
Get your veterinary autoimmune disease therapeutics market report here!
What are the leading drivers of growth in the veterinary autoimmune disease therapeutics market?
Rising investment in research pertaining to veterinary medicine is touted to boost the veterinary autoimmune disease therapeutics market’s growth in the future. Veterinary medicine, a medical specialty focusing on the prevention, diagnosis, and treatment of illnesses, disorders, and injuries in animals, is witnessing a surge in research funding. The increase in investment is thanks to escalating zoonotic diseases, a burgeoning pet market, advancements in animal health technology, mounting agricultural needs, and vigorous wildlife conservation initiatives. Such funding aids in studying disease functioning, diagnostic solutions, and treatment opportunities, thereby strengthening veterinary medicine’s potential to correctly diagnose and manage these disorders. In August 2024, as per the National Institute of Food and Agriculture, a US department of agriculture unveiled the Veterinary Service Grants Program (VSGP) alongside NIFA, committing $3.2 million to rural food animal veterinary medicine in the United States during the fiscal year 2022. Consequently, the expanding capital for veterinary medicine research is fueling the veterinary autoimmune disease therapeutics market’s progress.
What are the key segments defining the veterinary autoimmune disease therapeutics market?
The veterinary autoimmune disease therapeutics market covered in this report is segmented –
1) By Therapy Type: Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide, Levothyroxine, Folic Acid, Hydroxychloroquine, Chloroquine
2) By Animal Type: Companion Animals, Livestock Animals, Other Animals
3) By Disease: Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases
4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics
Subsegments:
1) By Corticosteroids: Prednisone, Prednisolone, Dexamethasone, Methylprednisolone, Triamcinolone
2) By Azathioprine: Azathioprine Oral Tablets, Azathioprine Injectable Formulation
3) By Cyclosporine: Oral Cyclosporine (Atopica), Injectable Cyclosporine
4) By Mycophenolate: Mycophenolate Mofetil (Oral Form), Mycophenolate Sodium (Injectable Form)
5) By Leflunomide: Leflunomide Tablets (Oral), Leflunomide Injection
6) By Cyclophosphamide: Oral Cyclophosphamide, Injectable Cyclophosphamide
7) By Levothyroxine: Levothyroxine Sodium Tablets (Oral), Levothyroxine Sodium Injection
8) By Folic Acid: Folic Acid Supplements (Oral), Injectable Folic Acid
9) By Hydroxychloroquine: Hydroxychloroquine Tablets (Oral), Hydroxychloroquine Injectable Formulation
10) By Chloroquine: Chloroquine Tablets (Oral), Chloroquine Injectable Formulation
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16208&type=smp
Which leading companies are shaping the growth of the veterinary autoimmune disease therapeutics market?
Major companies operating in the veterinary autoimmune disease therapeutics market are Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited
How are evolving market trends shaping veterinary autoimmune disease therapeutics Strategies?
In the veterinary autoimmune disease therapeutics market, major players like RenBiologics are prioritising the development of progressive, technology-driven solutions to attend to several pressing industry needs. RenBiologics is specifically geared towards innovating therapies for chronic ailments and kidney-related issues, with an emphasis on regenerative medicine and biologics to boost success rates in renal function and transplant scenarios. For instance, in January 2024, as per Biocytogen, a biotech firm based in China, a new subdivision called RenBiologics was initiated to concentrate on out-licensing fully human antibodies for therapeutic evolution. This tactic seeks to utilise Biocytogen’s comprehensive library of over 400,000 fully human antibody sequences, created via its exclusive RenMice platforms. RenBiologics plans to collaborate with biotechnology and pharmaceutical companies for co-development and licensing of these antibodies, thus optimising the probability for innovative antibody-based treatments. This unveiling underscores Biocytogen’s dedication to transforming into a global entity in antibody discovery, accelerating the evolution of avant-garde treatments in diverse therapeutic sectors.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16208
What regions are dominating the veterinary autoimmune disease therapeutics market growth?
North America was the largest region in the veterinary autoimmune disease therapeutics market in 2023. The regions covered in the veterinary autoimmune disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Pain Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report
Veterinary Dermatology Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-dermatology-drugs-global-market-report
Veterinary Medicine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-medicine-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
